Innovita Biological Technology Co., Ltd. (688253.SS) — Stock Score Summary

Innovita Biological Technology Co., Ltd. (688253.SS) has a MoatMap StockRank of 42/100 based on Quality (66/100), Value (14/100), and Momentum (49/100) factor scores. The current signal is HOLD. Innovita Biological Technology specializes in diagnostic test kits. It lacks structural pricing power, has a highly commoditized product portfolio, and does not align with our CDMO or advanced packaging themes.

Innovita Biological Technology is a biotechnology company specializing in point-of-care testing (POCT) and diagnostic reagents, particularly for respiratory infectious diseases. The company's competitive moat is sustained by its rapid-response diagnostic platforms and extensive distribution channels across Chinese hospitals. It is a prominent niche player in the domestic in-vitro diagnostics (IVD) market.

Key Financial Metrics

Price$8.40
Market Cap$1.1B
P/E (TTM)87.21
Price/Book3.70
Return on Equity4.3%
Return on Invested Capital7.8%
Debt/Equity0.45
Gross Margin73.2%
Operating Margin38.0%
Revenue Growth-47.4%
Dividend Yield1.0%
Free Cash Flow$198K

Innovita Biological Technology Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Innovita Biological Technology Co., Ltd.’s (688253.SS) StockRank?
MoatMap’s StockRank for Innovita Biological Technology Co., Ltd. (688253.SS) is 42/100, with a Hold signal. It is a composite of Quality (66), Value (14), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does Innovita Biological Technology Co., Ltd. have an economic moat?
Innovita Biological Technology Co., Ltd. (688253.SS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Innovita Biological Technology Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Innovita Biological Technology Co., Ltd. (688253.SS) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Innovita Biological Technology Co., Ltd. in?
Innovita Biological Technology Co., Ltd. (688253.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).